Chimeric antigen receptor (CAR) T-cell therapy is an example of gene engineering-based cellular therapy, which combines immunotherapy, gene therapy, and cellular therapy. Historically, the
See more from The Lancet Haematology
Third, Xiaolei Li and colleagues provide an overview of the historical and current regulatory reform in cellular therapy in China. #bmtsm #tcellrx https://t.co/o4cknXfSQH https://t.co/o4cknXfSQH - view on twitter